Evotec

Just – Evotec Biologics, a wholly owned subsidiary of Evotec SE, is an innovative and trusted CDMO for complex biologics, incl. mAbs, bi/multispecifics, and biosimilars. We provide our partners with highly differentiated services for the development and manufacturing of biologics. Our world-leading AI-driven in silico molecular optimization and continuous bioprocessing platforms combined with our revolutionary J.POD® facilities, which represent a paradigm shift within the industry, are helping to reduce the cost of goods and expand global access to affordable, high-quality biotherapeutics in addition to providing a highly agile cGMP manufacturing strategy to support rapid ramp up and uncertain demand scenarios.